Publisher
Springer Berlin Heidelberg
Reference293 articles.
1. Acred P, Ryan DM, Harding SM, Muggleton PW (1980) In vivo properties of GR 20263 [ceftazidime]. In: Nelson JD, Grassi C (eds) Current chemotherapy and infectious disease, vol. I. American Society for Microbiology, Washington, DC, pp 271–273
2. Actor P, Uri JV, Phillips L, Sachs CS, Guarini JR, Zajac I, Berges DA, Dunn GL, Hoover JRE, Weisbach JA (1975) Laboratory studies with cefatrizine (SK & F 60771) a new broad-spectrum orally-active cephalosporin. J Antibiot 28:594–601
3. Actor P, Pitkin DH, Lucyszin G, Weisbach JA, Bran JL (1976) Cefatrizine (SK & F 60771), a new oral cephalosporin: serum levels and urinary recovery in humans after oral or intramuscular administration—comparative study with cephalexin and cefazolin. Antimicrob Agents Chemother 9:800–803
4. Actor P, Uri JV, Zajac I, Guarini JR, Phillips L, Pitkin DH, Berges DA, Dunn GL, Hoover JRE, Weisbach JA (1978) SK & F 75073 (cefonicid), a new parenteral broad-spectrum cephalosporin with high and prolonged serum levels. Antimicrob Agents Chemother 13:784–790
5. Alfthan O, Renkonen OV, Ohlsson H (1979) Treatment with azlocillin in complicated urinary tract infectons. Arzneim Forsch 29:1919–1981
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献